For almost five decades, Elekta has been a leader in precision radiation medicine. Elekta’s inherent, innovative strength fuels the development of precision radiation medicine. We work actively to achieve a good balance between offering costeffective care to as many people as possible and the development of cutting-edge solutions for treating the most complicated forms of cancer.
This past year, Elekta reached pivotal milestones, shifting the treatment paradigm of radiation oncology for clinicians and patients across the globe. Elekta will continue to attentively assess its technologies, advancing new solutions to make cancer a more manageable disease. Our commitment is built on a combination of curiosity, innovation and proximity to our customers. We are proud to be the leading innovator in precision radiation medicine.
Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Linkedin/Instagram/Twitter.
